دورية أكاديمية

Randomized phase III trial of a neoadjuvant regimen of four cycles of adriamycin plus cyclophosphamide followed by four cycles of docetaxel (AC4-D4) versus a shorter treatment of three cycles of FEC followed by three cycles of docetaxel (FEC3-D3) in node-positive breast cancer (Neo-shorter; NCT02001506)

التفاصيل البيبلوغرافية
العنوان: Randomized phase III trial of a neoadjuvant regimen of four cycles of adriamycin plus cyclophosphamide followed by four cycles of docetaxel (AC4-D4) versus a shorter treatment of three cycles of FEC followed by three cycles of docetaxel (FEC3-D3) in node-positive breast cancer (Neo-shorter; NCT02001506)
المؤلفون: Hwang, InhwanAff1, Aff5, Kim, Jeong Eun, Jeong, Jae Ho, Ahn, Jin-Hee, Jung, Kyung Hae, Son, Byung Ho, Kim, Hak Hee, Shin, Junyoung, Lee, Hee Jin, Gong, Gyungyub, Kim, Sung-BaeAff1, IDs10549023069717_cor11
المصدر: Breast Cancer Research and Treatment. 201(2):193-204
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:01676806
15737217
DOI:10.1007/s10549-023-06971-7